Abstract
Developments in the field of sexology indicate a trend toward the medicalization of sexual issues which is likely to continue over the next decades. With the introduction of new pharmacological treatments, the resulting shift from the biopsychosocial model to the disease model will become increasingly accepted and solidified over the next decade. Some of this shift may be beneficial in that the healthcare needs of the patient/client may at times be better served through this route. However, concern arises when such shifts are likely to limit the meaningful choices presented to the patient and to dampen support for basic psycho-behavioral and neurophysiological sexological investigation. Such developments challenge sexologists and sex therapists to define their treatment outcomes more clearly and, relying on stronger evidence-based studies, define the critical role of the therapist in achieving these outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.